A clozapine's uncharted voyage: Five years and a pandemic after the end of mandatory haematological notifications to the Spanish medicines agency.

Andres-Olivera, Pilar; Turrion, Concha; Fernandez-Egea, Emilio; Perez, Jesus

Andres-Olivera, Pilar; Turrion, Concha; Fernandez-Egea, Emilio; Perez, Jesus.

Afiliación

Andres-Olivera P; Salamanca University Healthcare Complex (CAUSA), Salamanca, Spain; Institute of Biomedical Research of Salamanca (IBSAL), Psychiatry Unit, Department of Medicine, Universidad de Salamanca, Salamanca, Spain.
Turrion C; Institute of Biomedical Research of Salamanca (IBSAL), Psychiatry Unit, Department of Medicine, Universidad de Salamanca, Salamanca, Spain.
Fernandez-Egea E; Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK; Department of Psychiatry, University of Cambridge, Cambridge, UK.
Perez J; Salamanca University Healthcare Complex (CAUSA), Salamanca, Spain; Institute of Biomedical Research of Salamanca (IBSAL), Psychiatry Unit, Department of Medicine, Universidad de Salamanca, Salamanca, Spain; Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK; Department of Psychiatry

Rev Psiquiatr Salud Ment (Engl Ed) ; 15(4): 293-294, 2022.

Article en En | MEDLINE | ID: mdl-36513406

Asunto(s)

Clozapina; Humanos; Clozapina/efectos adversos; Pandemias

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Clozapina Límite: Humans Idioma: En Revista: Rev Psiquiatr Salud Ment (Engl Ed) Año: 2022 Tipo del documento: Article País de afiliación: España

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google